Growth Metrics

Cardlytics (CDLX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Cardlytics (CDLX) over the last 10 years, with Q3 2025 value amounting to $53.5 million.

  • Cardlytics' Shares Outstanding (Weighted Average) rose 692.61% to $53.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 692.61%. This contributed to the annual value of $48.4 million for FY2024, which is 3253.95% up from last year.
  • Cardlytics' Shares Outstanding (Weighted Average) amounted to $53.5 million in Q3 2025, which was up 692.61% from $52.8 million recorded in Q2 2025.
  • Cardlytics' Shares Outstanding (Weighted Average)'s 5-year high stood at $53.5 million during Q3 2025, with a 5-year trough of $29.3 million in Q1 2021.
  • For the 5-year period, Cardlytics' Shares Outstanding (Weighted Average) averaged around $39.7 million, with its median value being $34.9 million (2023).
  • As far as peak fluctuations go, Cardlytics' Shares Outstanding (Weighted Average) crashed by 43.27% in 2023, and later skyrocketed by 4064.22% in 2024.
  • Quarter analysis of 5 years shows Cardlytics' Shares Outstanding (Weighted Average) stood at $32.2 million in 2021, then rose by 3.78% to $33.4 million in 2022, then rose by 9.18% to $36.5 million in 2023, then skyrocketed by 32.54% to $48.4 million in 2024, then rose by 10.61% to $53.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $53.5 million for Q3 2025, versus $52.8 million for Q2 2025 and $51.9 million for Q1 2025.